Next Generation Sequencing Market Analysis By Application (HLA Testing, Prenatal Testing, Oncology, Idiopathic & Infectious Diseases), By Technology (Whole Genome Sequencing, Whole Exon Sequencing, Targeted Sequencing & Resequencing), By Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis) And Segment Forecasts To 2022
$3,840- June - 2015
- In Biotechnology
- By Grand View Research 1401 Views
The next generation sequencing market worldwide is anticipated to attain a market size of more than USD 25 billion by year 2022. The technological developments in genomic sequencing would lead to reduction in the sequencing cost per base pair and hence, resulting in enhancement of the usage and adoption usage rates of next generation sequencing during the forecast period……
The next generation sequencing market worldwide is anticipated to attain a market size of more than USD 25 billion by year 2022. The technological developments in genomic sequencing would lead to reduction in the sequencing cost per base pair and hence, resulting in enhancement of the usage and adoption usage rates of next generation sequencing during the forecast period. As a result of the introduction of novel phase resolved single cycle reads, the HLA and prenatal testing segments are expected to witness increase in the respective revenues. Further, the rise in the rate of incidences of cancer and infectious diseases would fuel the growth of the next generation sequencing market during the forecast period.
The major market participants of the next generation sequencing market include GATC Biotech AG., 454 Life Sciences Corp. (Roche Holding AG), Life Technologies (Thermo Fisher Scientific), Agilent Technologies Inc., Macrogen Inc., Pacific Biosciences, Beijing Genomics Institute, CLC bio (Qiagen), Illumina Inc., Biomatters Ltd., DNASTAR Inc., Qiagen NV., Knome Inc., Oxford Nanopore Technologies and Helicos BioSciences.
Key findings from the study:
In 2014, the Targeted sequencing & resequencing emerged as the leading technology segment of the market as a result of the swiftly rising demand in oncology and infectious diseases related research. Rising incidences of life frightening forms of cancer and infectious diseases would fuel the growth of this segment during the forecast period.
The next generation sequencing based oncology market is anticipated to top the market value during the forecast period. However, as a result of the introduction of the techniques useful for phase-resolved HLA and prenatal sequences in single cycle reads, the growth rate of the use of NGS in fields of HLA and prenatal testing are estimated to be relatively higher till 2022.
In 2014, the Next generation sequencing emerged as the largest workflow segment of the market. The segment growth would experience a trigger with the rising demand for personalized medicine and introduction of technologically advanced genome sequencing platforms during the forecast period.
Further, the Next generation sequencing based data analysis is anticipated to grow at a noticeably growth rate during the forecast period. Rise in the extensive R&D initiatives and the demand for storage and analysis are the key factors contributing to its fast growth.
In 2014, North America emerged as the major regional market. Heavy R&D investment for the development of genome sequencing, , rising adoption rates of whole genome sequencing, existence of the framework for the sophisticated technology and the reduction in sequencing cost per base pair are few of the factors responsible for the largest market share of North American geography.
Table of Content
Chapter 1. Executive Summary
1.1. Next Generation Sequencing – Industry Snapshot and Key Buying Criteria, 2012 - 2022
Chapter 2. Next Generation Sequencing Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Next Generation Sequencing Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Industry Analysis - Porter's
2.5. Key Opportunities Prioritized & Platform Positioning
2.5.1. Key Opportunities Prioritized
2.5.2. NGS Platform Positioning
2.6. Next Generation Sequencing Market PESTEL Analysis, 2014
2.7. Company Market Share Analysis, 2014
2.8. Product and competitive landscape analysis
2.8.1. Penetration levels
2.8.2. Comparative analysis
2.8.3. Application areas
Chapter 3. Next Generation Sequencing Application Outlook
3.1. HLA Testing
3.1.1. HLA Testing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
3.2. Prenatal Testing
3.2.1. Prenatal Testing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
3.3. Oncology
3.3.1. Oncology Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
3.4. Idiopathic Diseases
3.4.1. Idiopathic Diseases Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
3.5. Infectious Diseases
3.5.1. Infectious Diseases Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
Chapter 4. Next Generation Sequencing Technology Outlook
4.1. Whole Genome Sequencing
4.1.1. Whole Genome Sequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
4.2. Whole Exon Sequencing
4.2.1. Whole Exon Sequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
4.3. Targeted Sequencing & Resequencing
4.3.1. Targeted Sequencing & Resequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
Chapter 5. Next Generation Sequencing Workflow Outlook
5.1. NGS Pre-sequencing
5.1.1. NGS Pre-sequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
5.2. NGS Sequencing
5.2.1. NGS Sequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
5.3. NGS Data Analysis
5.3.1. NGS Data Analysis Market Estimates and Forecasts, 2012 – 2022 (USD Billion)
Chapter 6. Next Generation Sequencing Regional Outlook
6.1. North America
6.1.1. U.S.
6.1.1.1. U.S. Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.1.1.2. U.S. Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.1.1.3. U.S. Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.1.2. Canada
6.1.2.1. Canada Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.1.2.2. Canada Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.1.2.3. Canada Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.2. Europe
6.2.1. Germany
6.2.1.1. Germany Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.2.1.2. Germany Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.2.1.3. Germany Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.2.2. UK
6.2.2.1. UK Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.2.2.2. UK Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.2.2.3. UK Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.3. Asia Pacific
6.3.1. Japan
6.3.1.1. Japan Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.3.1.2. Japan Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.3.1.3. Japan Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.3.2. China
6.3.2.1. China Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.3.2.2. China Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.3.2.3. China Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.4. Latin America
6.4.1. Brazil
6.4.1.1. Brazil Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.4.1.2. Brazil Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.4.1.3. Brazil Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
6.5. MEA
6.5.1. South Africa
6.5.1.1. South Africa Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)
6.5.1.2. South Africa Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)
6.5.1.3. South Africa Next Generation Sequencing Market, by Workflow, 2012 – 2022 (USD Billion)
Chapter 7. Competitive Landscape
7.1. Illumina, Inc.
7.1.1. Company Overview
7.1.2. Revenue Analysis
7.1.3. Product Benchmarking
7.1.4. Strategic Development
7.2. 454 Life Sciences Corporation (Roche Holding Ag)
7.2.1. Company Overview
7.2.2. Revenue Analysis
7.2.3. Product Benchmarking
7.2.4. Strategic Development
7.3. Agilent Technologies, Inc.
7.3.1. Company Overview
7.3.2. Revenue Analysis
7.3.3. Product Benchmarking
7.3.4. Strategic Development
7.4. BGI (Beijing Genomics Institute)
7.4.1. Company Overview
7.4.2. Revenue Analysis
7.4.3. Product Benchmarking
7.4.4. Strategic Development
7.5. Biomatters, Ltd.
7.5.1. Company Overview
7.5.2. Revenue Analysis
7.5.3. Product Benchmarking
7.5.4. Strategic Development
7.6. CLC bio (Acquired By Qiagen)
7.6.1. Company Overview
7.6.2. Revenue Analysis
7.6.3. Product Benchmarking
7.6.4. Strategic Development
7.7. DNASTAR, Inc.
7.7.1. Company Overview
7.7.2. Revenue Analysis
7.7.3. Product Benchmarking
7.7.4. Strategic Development
7.8. GATC Biotech Ag
7.8.1. Company Overview
7.8.2. Revenue Analysis
7.8.3. Product Benchmarking
7.8.4. Strategic Development
7.9. Genomatix Software GmbH
7.9.1. Company Overview
7.9.2. Revenue Analysis
7.9.3. Product Benchmarking
7.9.4. Strategic Development
7.10. Knome, Inc.
7.10.1. Company Overview
7.10.2. Revenue Analysis
7.10.3. Product Benchmarking
7.10.4. Strategic Development
7.11. Life Technologies Corporation (Thermo Fisher Scientific)
7.11.1. Company Overview
7.11.2. Revenue Analysis
7.11.3. Product Benchmarking
7.11.4. Strategic Development
7.12. Macrogen, Inc.
7.12.1. Company Overview
7.12.2. Revenue Analysis
7.12.3. Product Benchmarking
7.12.4. Strategic Development
7.13. Oxford Nanopore Technologies, Ltd.
7.13.1. Company Overview
7.13.2. Revenue Analysis
7.13.3. Product Benchmarking
7.13.4. Strategic Development
7.14. Pacific Biosciences
7.14.1. Company Overview
7.14.2. Revenue Analysis
7.14.3. Product Benchmarking
7.14.4. Strategic Development
7.15. Partek Incorporated
7.15.1. Company Overview
7.15.2. Revenue Analysis
7.15.3. Product Benchmarking
7.15.4. Strategic Development
7.16. Perkin Elmer, Inc.
7.16.1. Company Overview
7.16.2. Revenue Analysis
7.16.3. Product Benchmarking
7.16.4. Strategic Development
7.17. Qiagen N.V.
7.17.1. Company Overview
7.17.2. Revenue Analysis
7.17.3. Product Benchmarking
7.17.4. Strategic Development
List of Tables
1. Next generation sequencing Market - Industry Summary & Key Buying Criteria
2. Next generation sequencing market, by application, 2012 - 2022 (USD Billion)
3. Next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
4. Next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
5. Next generation sequencing market, by region, 2012 - 2022 (USD Billion)
6. Next generation sequencing - Key market driver analysis
7. Next generation sequencing - Key market restraint analysis
8. Rating scale for platform positioning
9. North America market, by application, 2012 - 2022 (USD Billion)
10. North America market, by technology, 2012 - 2022 (USD Billion)
11. North America market, by workflow, 2012 - 2022 (USD Billion)
12. U.S. next generation sequencing market, by application, 2012 - 2022 (USD Billion)
13. U.S. next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
14. U.S. next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
15. Canada next generation sequencing market, by application, 2012 - 2022 (USD Billion)
16. Canada next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
17. Canada next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
18. Europe next generation sequencing market, by application, 2012 - 2022 (USD Billion)
19. Europe next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
20. Europe next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
21. Germany next generation sequencing market, by application, 2012 - 2022 (USD Billion)
22. Germany next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
23. Germany next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
24. UK next generation sequencing market, by application, 2012 - 2022 (USD Billion)
25. UK next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
26. UK next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
27. Asia Pacific market, by application, 2012 - 2022 (USD Billion)
28. Asia Pacific market, by technology, 2012 - 2022 (USD Billion)
29. Asia Pacific next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
30. Japan next generation sequencing market, by application, 2012 - 2022 (USD Billion)
31. Japan next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
32. Japan next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
33. China next generation sequencing market, by application, 2012 - 2022 (USD Billion)
34. China next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
35. China next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
36. Latin America market, by application, 2012 - 2022 (USD Billion)
37. Latin America market, by technology, 2012 - 2022 (USD Billion)
38. Latin America market, by workflow, 2012 - 2022 (USD Billion)
39. Brazil next generation sequencing market, by application, 2012 - 2022 (USD Billion)
40. Brazil next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
41. Brazil next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
42. MEA next generation sequencing market, by application, 2012 - 2022 (USD Billion)
43. MEA next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
44. MEA next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
45. South Africa market, by application, 2012 - 2022 (USD Billion)
46. South Africa market, by technology, 2012 - 2022 (USD Billion)
47. South Africa next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
List of Figures
1. Next Generation Sequencing: Market segmentation
2. Global next generation sequencing market, (USD Billion), 2012 - 2022
3. Next generation sequencing: Market dynamics
4. Next generation sequencing market - Porter’s Analysis
5. Key opportunities prioritized 2014
6. NGS Platform positioning
7. Next generation sequencing market - PESTEL analysis
8. Next generation sequencing: Company market share analysis, 2014
9. Next generation sequencing market share, by application, 2014 & 2022
10. Global HLA testing market, 2012 - 2022 (USD Billion)
11. Global prenatal testing market, 2012 - 2022 (USD Billion)
12. Global oncology market, 2012 - 2022 (USD Billion)
13. Global idiopathic diseases market, 2012 - 2022 (USD Billion)
14. Global infectious diseases market, 2012 - 2022 (USD Billion)
15. Next generation sequencing market share by technology, 2014 & 2022
16. Global whole genome sequencing market, 2012 - 2022 (USD Billion)
17. Global whole exon sequencing market, 2012 - 2022 (USD Billion)
18. Global panel sequencing & resequencig market, 2012 - 2022 (USD Billion)
19. Next generation sequencing market share by workflow, 2014 & 2022
20. Global NGS pre-sequencing market, 2012 - 2022 (USD Billion)
21. Global NGS sequencing market, 2012 - 2022 (USD Billion)
22. Global NGS data analysis market, 2012 - 2022 (USD Billion)
23. North America next generation sequencing market, 2012 - 2022 (USD Billion)
24. U.S. next generation sequencing market, 2012 - 2022 (USD Billion)
25. Canada next generation sequencing market, 2012 - 2022 (USD Billion)
26. Europe next generation sequencing market, 2012 - 2022 (USD Billion)
27. Germany next generation sequencing market, 2012 - 2022 (USD Billion)
28. UK next generation sequencing market, 2012 - 2022 (USD Billion)
29. Asia Pacific next generation sequencing market, 2012 - 2022 (USD Billion)
30. Japan next generation sequencing market, 2012 - 2022 (USD Billion)
31. China next generation sequencing market, 2012 - 2022 (USD Billion)
32. Latin America next generation sequencing market, 2012 - 2022 (USD Billion)
33. Brazil next generation sequencing market, 2012 - 2022 (USD Billion)
34. MEA next generation sequencing market, 2012 - 2022 (USD Billion)
35. South Africa next generation sequencing market, 2012 - 2022 (USD Billion)
